Back to search

Peptide record

TPDB92494

RW-AH Antibacterial Anticancer Toxicity standard
18 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB92494
RW-AH
Antibacterial Anticancer Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
Peptipedia CancerPPD 2.0
standard
No
A 18-aa standard natural multi-activity (Antibacterial, Anticancer, and Toxicity) peptide sequence curated from Peptipedia and CancerPPD 2.0, with an available 3D structural model.
C-terminal: Amidation
Sequence
WWRRWWRRWRRWWRRWWR-NH2
Physicochemical Analysis
C153H200N54O19
ANDCEQGHILKMFPSTYV
RW
3099.62
13.30
9
0
9
+9
-9.36
-2.700
0.00
Mammalian: 2.8 hour Yeast: 3 min E.coli: 2 min
49500
1596.97
0
Residue Composition
number
0
A
9
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
0
I
0
L
0
K
0
M
0
F
0
P
0
S
0
T
9
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 9 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 0 L: 0 K: 0 M: 0 F: 0 P: 0 S: 0 T: 0 W: 9 Y: 0 V: 0
Chemical Descriptors
18
C153H200N54O19
3099.62
13.30
+9
-9.36
-2.700
Amidation
L
Linear
Free
Host Defence Peptide
Synthetic
Evidence Records 3 records
Evidence 1 Activity

Activity

LC50
LC50 = 4.5 ± 0.02 µM
Anticancer
4.5

Target

Skin Cancer
A-375
Skin

Assay & Model

PI uptake assay
8-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2015

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

LC50
LC50 = 8.4 ± 0.5 µM
Anticancer
8.4

Target

Skin Cancer
A-375
Skin

Assay & Model

MTS assay
24-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2015
Evidence 3 Activity

Activity

LC50
LC50 = 4.6 ± 0.2 µM
Anticancer
4.6

Target

Skin Cancer
SBcl2
Skin

Assay & Model

MTS assay
24-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2015